High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy (Q40728614)

23 September 2017

title

High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy (English)

1 reference

23 September 2017

1 reference

Yu H

1 reference

23 September 2017

Rifai N

series ordinal

1 reference

23 September 2017

publication date

1 November 2000

1 reference

23 September 2017

published in

Clinical Biochemistry

1 reference

23 September 2017

1 reference

23 September 2017

1 reference

23 September 2017

page(s)

601-610

1 reference

Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Molecular bases of the acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

C-reactive protein fifty years on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Hormone replacement therapy and increased plasma concentration of C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Complement activation by C-reactive protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Independent prognostic value of elevated C-reactive protein in unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900186-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9120(00)00186-7

1 reference

23 September 2017

1 reference